Ignite Creation Date:
2025-12-24 @ 9:37 PM
Ignite Modification Date:
2025-12-30 @ 5:40 PM
Study NCT ID:
NCT04332432
Status:
COMPLETED
Last Update Posted:
2022-03-28
First Post:
2020-03-24
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Single-dose, Open-label, Pharmacokinetic Study of Belapectin (GR-MD-02) in Subjects With Normal Hepatic Function and Subjects With Varying Degrees of Hepatic Impairment
Sponsor:
Galectin Therapeutics Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-06-16
Start Date Type:
ACTUAL
Primary Completion Date:
2022-03-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-03-09
Completion Date Type:
ACTUAL
First Submit Date:
2020-03-24
First Submit QC Date:
None
Study First Post Date:
2020-04-02
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-03-24
Last Update Post Date:
2022-03-28
Last Update Post Date Type:
ACTUAL